Loading organizations...
Key people at Highline Capital Management.
Highline Capital Management was founded in 1995 by Jacob Doft (Founder & CEO).
Highline Capital Management, L.P. operates as a New York City-based investment firm specializing in managing portfolios of mid and large capitalization U.S. equities. The firm employs a rigorous fundamental research approach to identify investment opportunities, utilizing both long and short positions to navigate market dynamics and construct portfolios with attractive risk-adjusted returns.
The company was founded in 1995 by Jacob W. Doft, who also serves as its portfolio manager. Doft established Highline Capital with the core principle of leveraging in-depth fundamental analysis to uncover mispriced assets within the U.S. equity markets, aiming to deliver consistent performance regardless of broader market movements.
Highline Capital Management primarily serves institutional investors and high-net-worth individuals seeking sophisticated equity strategies. The firm's long-term vision centers on disciplined, research-driven investing, continually adapting its strategies to capitalize on evolving market conditions and preserve capital while generating growth for its discerning client base.
Highline Capital Management was founded in 1995 by Jacob Doft (Founder & CEO).
Key people at Highline Capital Management.
Highline Capital Management has 4 tracked investments across 4 companies. The latest tracked deal is $37.0M Series C in Proscia in June 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 14, 2022 | Proscia | $37.0M Series C | Highline Capital Management | — |
| Mar 30, 2021 | Tomorrow.io | $77.0M Series D | Richard Davis | — |
| Mar 4, 2021 | atai Life Sciences | $157.0M Series D | Christian Angermayer, Apeiron Investment Group, Thiel Capital | Catalio Capital, Falcon Edge Capital, Fearless Ventures, Pura Vida Investments, Michael Auerbach, Woodline Partners |
| Sep 1, 2019 | Passage Bio | $110.0M Series B | Access Biotechnology | ARCH Venture Partners, Atlas Venture, Domain Associates, Frazier Healthcare Partners, GE Ventures, InterWest, OrbiMed, Polaris Partners, SV Health Investors, Wildcat Ventures, Boxer Capital, Lilly Asia Ventures, Logos Capital, NEW Leaf Venture Partners, Sphera Funds Management, Versant Ventures, Vivo Capital |